Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management
Authors
Keywords
-
Journal
Journal of Personalized Medicine
Volume 11, Issue 11, Pages 1102
Publisher
MDPI AG
Online
2021-10-28
DOI
10.3390/jpm11111102
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MO01.32 CodeBreaK 200: A Phase 3 Multicenter Study of Sotorasib, a KRAS(G12C) Inhibitor, versus Docetaxel in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC) Harboring KRAS p.G12C Mutation
- (2021) M. Reck et al. Journal of Thoracic Oncology
- Cancer statistics for the year 2020: An overview
- (2021) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- KRYSTAL-12: A randomized phase 3 study of adagrasib (MRTX849) versus docetaxel in patients (pts) with previously treated non-small-cell lung cancer (NSCLC) with KRASG12C mutation.
- (2021) Tony S. K. Mok et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab Deruxtecan in HER2-Mutant Non–Small-Cell Lung Cancer
- (2021) Bob T. Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- A TP53-associated gene signature for prediction of prognosis and therapeutic responses in lung squamous cell carcinoma
- (2020) Feng Xu et al. OncoImmunology
- Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages
- (2020) Nicolas Guibert et al. European Respiratory Review
- Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis
- (2020) Kang Qin et al. BMC CANCER
- A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Therapy: JUNIPER
- (2020) Jonathan W. Goldman et al. Frontiers in Oncology
- RET fusion in advanced non-small-cell lung cancer and response to cabozantinib
- (2019) Yucong Wang et al. MEDICINE
- Tim-3/galectin-9 pathway and mMDSC control primary and secondary resistances to PD-1 blockade in lung cancer patients
- (2019) Emeric Limagne et al. OncoImmunology
- Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines
- (2019) Claudia Fumarola et al. Frontiers in Oncology
- Development of treatment options for Chinese patients with advanced squamous cell lung cancer: focus on afatinib
- (2019) Shun Lu OncoTargets and Therapy
- Role of PD-L1 Expression in Non-Small Cell Lung Cancer and Their Prognostic Significance according to Clinicopathological Factors and Diagnostic Markers
- (2019) Konrad Pawelczyk et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Detection of NRG1 Gene Fusions in Solid Tumors
- (2019) Sushma Jonna et al. CLINICAL CANCER RESEARCH
- The Roles of MicroRNA in Lung Cancer
- (2019) Kuan-Li Wu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chemotherapy in KRAS-mutated chemotherapy naive non-small cell lung cancer patients: A phase III comparing cisplatin-pemetrexed with carboplatin-paclitaxel-bevacizumab: NVALT 22 (NCT02743923).
- (2019) Anne-Marie C. Dingemans et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic value of TGF-β in lung cancer: systematic review and meta-analysis
- (2019) Jue Li et al. BMC CANCER
- Targeting ROS1 Rearrangements in Non-small Cell Lung Cancer: Crizotinib and Newer Generation Tyrosine Kinase Inhibitors
- (2019) Tessa A. Morris et al. DRUGS
- Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy
- (2019) Pengfei Zhao et al. Journal of Hematology & Oncology
- Enhancement of diagnostic performance in lung cancers by combining CEA and CA125 with autoantibodies detection
- (2019) Ruochuan Zang et al. OncoImmunology
- Fibroblast Growth Factor Receptors (FGFRs): Structures and Small Molecule Inhibitors
- (2019) Shuyan Dai et al. Cells
- HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers
- (2019) Fatemeh Moosavi et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- The association between BRAF mutation class and clinical features in BRAF-mutant Chinese non-small cell lung cancer patients
- (2019) Quan Lin et al. Journal of Translational Medicine
- Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment
- (2019) Narjust Duma et al. MAYO CLINIC PROCEEDINGS
- New Horizons in KRAS-Mutant Lung Cancer: Dawn After Darkness
- (2019) Haitang Yang et al. Frontiers in Oncology
- 1969PTargeting NRG1-fusions in multiple tumour types: Afatinib as a novel potential treatment option
- (2019) S V Liu et al. ANNALS OF ONCOLOGY
- Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
- (2019) P. Garrido et al. Clinical & Translational Oncology
- Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours
- (2019) Robin L. Jones et al. EUROPEAN JOURNAL OF CANCER
- P1.01-113 Phase 1b Trial of Cabozantinib or Cabozantinib Plus Atezolizumab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
- (2019) F. Lim et al. Journal of Thoracic Oncology
- P1.14-50 A Phase 2 Trial of Cabozantinib in ROS1-Rearranged Lung Adenocarcinoma
- (2019) R. Guo et al. Journal of Thoracic Oncology
- EP1.04-11 Frequency of Microsatellite Instability (MSI) in Brazilian TKI Non-Treatable Non-Small Cell Lung Cancer (NSCLC) Patients
- (2019) P. De Marchi et al. Journal of Thoracic Oncology
- Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial
- (2019) Alice T Shaw et al. LANCET ONCOLOGY
- Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
- (2018) Neal I. Lindeman et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- The anti-tumor effect of regorafenib in lung squamous cell carcinoma in vitro
- (2018) Xiu Hu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- LAG-3 in Non–Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival
- (2018) Sigurd M. Hald et al. Clinical Lung Cancer
- Algorithm for the treatment of advanced or metastatic squamous non-small-cell lung cancer: an evidence-based overview
- (2018) N. Daaboul et al. Current Oncology
- Biomarker definitions and their applications
- (2018) Robert M Califf EXPERIMENTAL BIOLOGY AND MEDICINE
- Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
- (2018) Claudia Allemani et al. LANCET
- Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer
- (2018) Z.F. Jiang et al. LIFE SCIENCES
- The role of tumor-infiltrating lymphocytes (TILs) as a predictive biomarker of response to anti-PD1 therapy in patients with metastatic non-small cell lung cancer or metastatic melanoma
- (2018) Anton Uryvaev et al. MEDICAL ONCOLOGY
- KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target
- (2018) Marta Román et al. Molecular Cancer
- Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
- (2018) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune Checkpoint Blockade: The New Frontier in Cancer Treatment
- (2018) Jeffrey M. Clarke et al. Targeted Oncology
- TP53 mutations and SNPs as prognostic and predictive factors in patients with breast cancer (Review)
- (2018) Joanna Huszno et al. Oncology Letters
- Expression ratio of the TGFβ-inducible gene MYO10 is prognostic for overall survival of squamous cell lung cancer patients and predicts chemotherapy response
- (2018) D. Dvornikov et al. Scientific Reports
- ALK- rearrangement in non-small-cell lung cancer (NSCLC)
- (2018) Xue Du et al. Thoracic Cancer
- Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease
- (2018) Michael M. Boyiadzis et al. Journal for ImmunoTherapy of Cancer
- An Update on Predictive Biomarkers for Treatment Selection in Non-Small Cell Lung Cancer
- (2018) Tamkin Ahmadzada et al. Journal of Clinical Medicine
- OUP accepted manuscript
- (2018) ANNALS OF ONCOLOGY
- Prognostic value of aberrantly expressed methylation gene profiles in lung squamous cell carcinoma: A study based on The Cancer Genome Atlas
- (2018) Chundi Gao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Preselection of lung cancer cases using FGFR1 mRNA and gene copy number for treatment with ponatinib.
- (2018) Terry L. Ng et al. JOURNAL OF CLINICAL ONCOLOGY
- Brigatinib versus Crizotinib in ALK-Positive Non–Small-Cell Lung Cancer
- (2018) D. Ross Camidge et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
- (2018) Luis Paz-Ares et al. NEW ENGLAND JOURNAL OF MEDICINE
- Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patients
- (2018) Zahra Fathi et al. PLoS One
- Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small cell lung cancer; a CSCO-ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS
- (2018) Y -L Wu et al. ANNALS OF ONCOLOGY
- Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy
- (2018) Jean-David Fumet et al. BRITISH JOURNAL OF CANCER
- Lung cancer biopsy: Can diagnosis be changed after immunohistochemistry when the H&E-Based morphology corresponds to a specific tumor subtype?
- (2018) FDC Bernardi et al. Clinics
- A two-miRNA signature (miR-33a-5p and miR-128-3p) in whole blood as potential biomarker for early diagnosis of lung cancer
- (2018) Jinchang Pan et al. Scientific Reports
- The Evaluation of Serum Biomarkers for Non-small Cell Lung Cancer (NSCLC) Diagnosis
- (2018) Rui Fang et al. Frontiers in Physiology
- Tumor mutation burden in lung cancer: a new predictive biomarker for immunotherapy or too soon to tell?
- (2018) Mariam Alexander et al. Journal of Thoracic Disease
- LAG3 (CD223) as a cancer immunotherapy target
- (2017) Lawrence P. Andrews et al. IMMUNOLOGICAL REVIEWS
- Comparison of gefitinib, erlotinib and afatinib in non-small cell lung cancer: A meta-analysis
- (2017) Zuyao Yang et al. INTERNATIONAL JOURNAL OF CANCER
- Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non–Small Cell Lung Cancer
- (2017) Pasi A. Jänne et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1–Selected Advanced Non–Small-Cell Lung Cancer (BIRCH)
- (2017) Solange Peters et al. JOURNAL OF CLINICAL ONCOLOGY
- Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
- (2017) Nasser Hanna et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry
- (2017) Oliver Gautschi et al. JOURNAL OF CLINICAL ONCOLOGY
- A Case of Invasive Mucinous Pulmonary Adenocarcinoma with a CD74-NRG1 Fusion Protein Targeted with Afatinib
- (2017) Parneet K. Cheema et al. Journal of Thoracic Oncology
- MA04.02 Neratinib ± Temsirolimus in HER2-Mutant Lung Cancers: An International, Randomized Phase II Study
- (2017) Leena Gandhi et al. Journal of Thoracic Oncology
- Durable Response to Afatinib in Lung Adenocarcinoma Harboring NRG1 Gene Fusions
- (2017) Nathan D. Gay et al. Journal of Thoracic Oncology
- LAG-3 Protein Expression in Non–Small Cell Lung Cancer and Its Relationship with PD-1/PD-L1 and Tumor-Infiltrating Lymphocytes
- (2017) Yayi He et al. Journal of Thoracic Oncology
- Ceritinib versus chemotherapy in patients with ALK -rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial
- (2017) Alice T Shaw et al. LANCET ONCOLOGY
- Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer
- (2017) Naomi Kobayashi-Watanabe et al. LUNG CANCER
- DNA mismatch repair deficiency in surgically resected lung adenocarcinoma: Microsatellite instability analysis using the Promega panel
- (2017) Kazuya Takamochi et al. LUNG CANCER
- Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab
- (2017) Stefan Diem et al. LUNG CANCER
- Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer
- (2017) Stephen J. Bagley et al. LUNG CANCER
- Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer
- (2017) Solange Peters et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy
- (2017) Lais Osmani et al. SEMINARS IN CANCER BIOLOGY
- EGFR G796D mutation mediates resistance to osimertinib
- (2017) Di Zheng et al. Oncotarget
- Functional Expression of Programmed Death-Ligand 1 (B7-H1) by Immune Cells and Tumor Cells
- (2017) Rachel M. Gibbons Johnson et al. Frontiers in Immunology
- Non-Canonical Thinking for Targeting ALK-Fusion Onco-Proteins in Lung Cancer
- (2017) Wei Wu et al. Cancers
- The frequency and clinical impact of HER2 alterations in lung adenocarcinoma
- (2017) Eun Kyung Kim et al. PLoS One
- Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboringRETrearrangement: a phase II clinical trial
- (2016) S.-H. Lee et al. ANNALS OF ONCOLOGY
- Impact of Recent Developments in Lung Cancer on the Practice of Pathology
- (2016) Philip T. Cagle et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Proteolytic processing of Neuregulin-1
- (2016) Michael Willem BRAIN RESEARCH BULLETIN
- Efficacy and safety of dovitinib in pretreated patients with advanced squamous non-small cell lung cancer withFGFR1amplification: A single-arm, phase 2 study
- (2016) Sung Hee Lim et al. CANCER
- The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer
- (2016) Jennifer L. Hsu et al. CANCER AND METASTASIS REVIEWS
- Fibroblast Growth Factor Receptor 1 Gene Amplification in Nonsmall Cell Lung Cancer
- (2016) Rui-Juan Liu et al. CHINESE MEDICAL JOURNAL
- Prognostic and Predictive Effect of TP53 Mutations in Patients with Non–Small Cell Lung Cancer from Adjuvant Cisplatin–Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis
- (2016) Xiaoli Ma et al. Journal of Thoracic Oncology
- The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics
- (2016) Ting-Yuan David Cheng et al. Journal of Thoracic Oncology
- The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
- (2016) Peter Goldstraw et al. Journal of Thoracic Oncology
- Cabozantinib in patients with advanced RET -rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial
- (2016) Alexander Drilon et al. LANCET ONCOLOGY
- Clinical characteristics and outcome of patients with lung cancer harboring BRAF mutations
- (2016) Claire Tissot et al. LUNG CANCER
- ALK, ROS1 and RET rearrangements in lung squamous cell carcinoma are very rare
- (2016) Weijie Zhao et al. LUNG CANCER
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application
- (2016) Young Kwang Chae et al. Oncotarget
- Plasma miR-324-3p and miR-1285 as diagnostic and prognostic biomarkers for early stage lung squamous cell carcinoma
- (2016) Xujie Gao et al. Oncotarget
- KIAA1522 is a novel prognostic biomarker in patients with non-small cell lung cancer
- (2016) Yi-Zhen Liu et al. Scientific Reports
- Discoidin Domain Receptors: Potential Actors and Targets in Cancer
- (2016) Hassan Rammal et al. Frontiers in Pharmacology
- PD-L1 biomarker testing for non-small cell lung cancer: truth or fiction?
- (2016) Claud Grigg et al. Journal for ImmunoTherapy of Cancer
- Ki-67 as a prognostic marker in early-stage non-small cell lung cancer in Asian patients: a meta-analysis of published studies involving 32 studies
- (2015) Song Wen et al. BMC CANCER
- Clinical and prognostic significance of OPN and VEGF expression in patients with non-small-cell lung cancer
- (2015) Qunying Lin et al. Cancer Epidemiology
- The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing
- (2015) T. Helsten et al. CLINICAL CANCER RESEARCH
- Phase III Multinational, Randomized, Double-Blind, Placebo-Controlled Study of Tivantinib (ARQ 197) Plus Erlotinib Versus Erlotinib Alone in Previously Treated Patients With Locally Advanced or Metastatic Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Giorgio Scagliotti et al. JOURNAL OF CLINICAL ONCOLOGY
- miR-Test: A Blood Test for Lung Cancer Early Detection
- (2015) Francesca Montani et al. JNCI-Journal of the National Cancer Institute
- MiR-205 and MiR-375 MicroRNA Assays to Distinguish Squamous Cell Carcinoma from Adenocarcinoma in Lung Cancer Biopsies
- (2015) Santosh Patnaik et al. Journal of Thoracic Oncology
- The 2015 World Health Organization Classification of Lung Tumors
- (2015) William D. Travis et al. Journal of Thoracic Oncology
- Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer
- (2015) Victoria Doseeva et al. Journal of Translational Medicine
- Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring MET Mutations Causing Exon 14 Skipping
- (2015) P. K. Paik et al. Cancer Discovery
- miR-Test: A Blood Test for Lung Cancer Early Detection
- (2015) Francesca Montani et al. JNCI-Journal of the National Cancer Institute
- A Five-miRNA Panel Identified From a Multicentric Case–control Study Serves as a Novel Diagnostic Tool for Ethnically Diverse Non-small-cell Lung Cancer Patients
- (2015) Cheng Wang et al. EBioMedicine
- TGF-β1 Protein Expression in Non-Small Cell Lung Cancers is Correlated with Prognosis
- (2014) Ai-Li Huang et al. Asian Pacific Journal of Cancer Prevention
- Clinical Utility of a Plasma-Based miRNA Signature Classifier Within Computed Tomography Lung Cancer Screening: A Correlative MILD Trial Study
- (2014) Gabriella Sozzi et al. JOURNAL OF CLINICAL ONCOLOGY
- Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial
- (2014) Martin Reck et al. LANCET ONCOLOGY
- BRAF-mutations in non-small cell lung cancer
- (2014) Odd Terje Brustugun et al. LUNG CANCER
- The landscape of kinase fusions in cancer
- (2014) Nicolas Stransky et al. Nature Communications
- Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with aG551DMutation
- (2013) Jane C. Davies et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin
- (2013) M Tiseo et al. BRITISH JOURNAL OF CANCER
- Phase 1 study of lenvatinib combined with carboplatin and paclitaxel in patients with non-small-cell lung cancer
- (2013) M Nishio et al. BRITISH JOURNAL OF CANCER
- KIF5B-RETfusions in Chinese patients with non-small cell lung cancer
- (2013) Weijing Cai et al. CANCER
- Crizotinib in the Treatment of Non–Small-Cell Lung Cancer
- (2013) Sacha I. Rothschild et al. Clinical Lung Cancer
- The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
- (2013) Graeme J.K. Guthrie et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Lung Cancer That Harbors an HER2 Mutation: Epidemiologic Characteristics and Therapeutic Perspectives
- (2013) Julien Mazières et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology
- (2013) Neal I. Lindeman et al. Journal of Thoracic Oncology
- Validation of a Histology-Independent Prognostic Gene Signature for Early-Stage, Non–Small-Cell Lung Cancer Including Stage IA Patients
- (2013) Sandy D. Der et al. Journal of Thoracic Oncology
- Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer
- (2013) Kyoko Okamura et al. LUNG CANCER
- Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer
- (2013) Aria Vaishnavi et al. NATURE MEDICINE
- Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
- (2013) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proteins involved in DNA damage response pathways and survival of stage I non-small-cell lung cancer patients
- (2012) C. M. Choi et al. ANNALS OF ONCOLOGY
- Role of pemetrexed in advanced non-small-cell lung cancer: meta-analysis of randomized controlled trials, with histology subgroup analysis
- (2012) K. Alsaleh et al. Current Oncology
- Crizotinib in the treatment of non-small-cell lung cancer
- (2012) Patrick M Forde et al. EXPERT OPINION ON PHARMACOTHERAPY
- miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes
- (2012) Yong-Kui Zhang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers
- (2012) Kristin Bergethon et al. JOURNAL OF CLINICAL ONCOLOGY
- Classification of the Four Main Types of Lung Cancer Using a MicroRNA-Based Diagnostic Assay
- (2012) Shlomit Gilad et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Structure of the Discoidin Domain Receptor 1 Extracellular Region Bound to an Inhibitory Fab Fragment Reveals Features Important for Signaling
- (2012) Federico Carafoli et al. STRUCTURE
- Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials
- (2011) T. Reiman et al. ANNALS OF ONCOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- TP53 Mutations in Nonsmall Cell Lung Cancer
- (2011) Akira Mogi et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
- (2011) William D. Travis et al. Journal of Thoracic Oncology
- What’s new in non-small cell lung cancer for pathologists the importance of accurate subtyping, EGFR mutations and ALK rearrangements
- (2011) Wendy A. Cooper et al. PATHOLOGY
- Histology as a treatment effect modifier in advanced non-small cell lung cancer: A systematic review of the evidence
- (2011) LACHLAN STANDFIELD et al. RESPIROLOGY
- Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
- (2011) Peter S. Hammerman et al. Cancer Discovery
- Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity
- (2010) David G. DeNardo et al. CANCER AND METASTASIS REVIEWS
- Accurate Classification of Non-Small Cell Lung Carcinoma Using a Novel MicroRNA-Based Approach
- (2010) J. A. Bishop et al. CLINICAL CANCER RESEARCH
- The MicroRNA Spectrum in 12 Body Fluids
- (2010) J. A. Weber et al. CLINICAL CHEMISTRY
- Phase II Proof-of-Concept Study of Pazopanib Monotherapy in Treatment-Naive Patients With Stage I/II Resectable Non–Small-Cell Lung Cancer
- (2010) Nasser Altorki et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Value of Vascular Endothelial Growth Factor Expression in Patients with Lung Cancer: A Systematic Review with Meta-Analysis
- (2010) Ping Zhan et al. Journal of Thoracic Oncology
- Clinical Use of Interferon-γ
- (2009) Catriona H.T. Miller et al. Annals of the New York Academy of Sciences
- The epidermal growth factor system of ligands and receptors in cancer
- (2009) William J. Gullick EUROPEAN JOURNAL OF CANCER
- Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non–Small-Cell Lung Carcinoma
- (2009) Danit Lebanony et al. JOURNAL OF CLINICAL ONCOLOGY
- Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy
- (2008) Stuart Thomson et al. CLINICAL & EXPERIMENTAL METASTASIS
- An Immune Response Enriched 72-Gene Prognostic Profile for Early-Stage Non-Small-Cell Lung Cancer
- (2008) P. Roepman et al. CLINICAL CANCER RESEARCH
- Transforming growth factor-beta (TGF-β) and brain tumours
- (2008) Rodney B. Luwor et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Class III β-Tubulin Is a Component of the Mitotic Spindle in Multiple Cell Types
- (2008) Eeva-Mari Jouhilahti et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study
- (2008) Kerby Shedden et al. NATURE MEDICINE
- Autoantibodies in lung cancer: possibilities for early detection and subsequent cure
- (2007) C J Chapman et al. THORAX
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now